Jakob Raffler

Jakob Raffler

Auto-generated profile, based on publicly available information

Jakob Raffler

Institute of Applied Synthetic Chemistry TU Wien Getreidemarkt 9 1060 Vienna Austria

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2024 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
MRMichal Rahm
Michal Rahm
PKPatrick Keppel
Patrick Keppel
VŠVeronika Šlachtová
Veronika Šlachtová
RDRastislav Dzijak
Rastislav Dzijak
MDMartin Dracinsky
Martin Dracinsky
MVMilan Vrabel
Milan Vrabel
Bioorthogonal reactions that enable switching molecular functions by breaking chemical bonds have gained prominence, with the tetrazine‐mediated cleavage of trans‐cyclooctene caged compounds (click‐to‐release) being particularly noteworthy for its high versatility, biocompatibility, and fast reaction rates. Despite several recent advances, the development of highly reactive tetrazines enabling quantitative elimination from trans‐cyclooctene linkers remains challenging. In this study, we present the synthesis and application of sulfo‐tetrazines, a class of derivatives featuring phenolic hydroxyl groups with increased acidity constants (pKa). This unique property leads to accelerated elimination and complete release of the caged molecules within minutes. Moreover, the inclusion of sulfonate groups provides a valuable synthetic handle, enabling further derivatization into sulfonamides, modified with diverse substituents. Significantly, we demonstrate the utility of sulfo‐tetrazines in efficiently activating fluorogenic compounds and prodrugs in living cells, offering exciting prospects for their application in bioorthogonal chemistry.

31 October 2024 in Angewandte Chemie
Verified
Journal Article
Open access
MRMichal Rahm
Michal Rahm
PKPatrick Keppel
Patrick Keppel
VŠVeronika Šlachtová
Veronika Šlachtová
RDRastislav Dzijak
Rastislav Dzijak
MDMartin Dracinsky
Martin Dracinsky
MVMilan Vrabel
Milan Vrabel
Bioorthogonal reactions that enable switching molecular functions by breaking chemical bonds have gained prominence, with the tetrazine‐mediated cleavage of trans‐cyclooctene caged compounds (click‐to‐release) being particularly noteworthy for its high versatility, biocompatibility, and fast reaction rates. Despite several recent advances, the development of highly reactive tetrazines enabling quantitative elimination from trans‐cyclooctene linkers remains challenging. In this study, we present the synthesis and application of sulfo‐tetrazines, a class of derivatives featuring phenolic hydroxyl groups with increased acidity constants (pKa). This unique property leads to accelerated elimination and complete release of the caged molecules within minutes. Moreover, the inclusion of sulfonate groups provides a valuable synthetic handle, enabling further derivatization into sulfonamides, modified with diverse substituents. Significantly, we demonstrate the utility of sulfo‐tetrazines in efficiently activating fluorogenic compounds and prodrugs in living cells, offering exciting prospects for their application in bioorthogonal chemistry.

5 November 2026 in The Journal of Organic Chemistry
Verified
Journal Article
Open access
SHSebastian Hecko
Sebastian Hecko
SSSebastian Schnöll
Sebastian Schnöll
JRJakob E. Raffler
Jakob E. Raffler
ALAndreas Löffler
Andreas Löffler
JBJohannes Bintinger
Johannes Bintinger
HMHannes Mikula
Hannes Mikula
The tetrazine-trans-cyclooctene (Tz-TCO) click-to-release reaction is widely used for bioorthogonal payload release in chemical biology and drug delivery. The recently developed intramolecularly controlled click-cleavable trans-cyclooctene linker iTCO enables fast, near-quantitative release across diverse tetrazine classes, but its broader use has been limited by a lengthy, low-yielding synthesis (eleven steps, ∼1% overall yield). We report a seven-step route centered on a telescoped flow photohydrolysis-iodolactonization sequence, providing gram-scale access to iTCO in 8% overall yield.